Pfizer Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (411)

View All

Latest Posts

About This Stock More About This Stock
Week In Review: How Trump's Policies Moved Stocks - May 12, 2019
Article By: The Fly
Sunday, May 12, 2019 6:43 AM EDT
Catch up on the top industries and stocks that were impacted, by the comments, actions and policies of President Donald Trump and his administration with this weekly recap.
In this article: AZN, BMY, GM, GSK, JNJ, LLY, MRK, NVS, PFE, SNY, RHHBY, WKHS
Read
Undervalued Growth And Dividend Growth In Health Technology
Article By: Chuck Carnevale
Wednesday, March 20, 2019 11:13 AM EDT
Although many Health Technology Sector companies have significantly outperformed the market on a long-term basis, they have significantly underperformed the market since the beginning of 2015.
In this article: ABBV, AGN, AMGN, BMY, BIIB, CELG, GILD, MYL, PFE, PRGO
Read
Pfizer Prices US$5bn Bond As Corporate Debt Deluge Continues
Article By: Interactive Brokers
Tuesday, March 5, 2019 3:00 PM EDT
Pfizer said it will peg proceeds from the sale for general corporate purposes, including to refinance, redeem or repurchase existing debt and to repay a portion of its outstanding commercial paper.
In this article: PFE Also: GSK, XLV, SPX, BMY, CELG, JUNO
Read
E Daily Stock Pick: Pfizer Inc
Article By: Fredrik Arnold
Tuesday, February 26, 2019 5:22 AM EDT
Pfizer's price per share closed at $43.33 yesterday. A year ago its price was $36.26. Price rose $41.52 per share last year, or almost 19.5%.
In this article: PFE
Read
Dogs Of The Dow And A 3 Top Dogs Strategy
Article By: MoneyShow.com
Sunday, February 17, 2019 10:12 AM EDT
The “Dogs of the Dow” is one of the simplest, most well-known dividend strategies on Wall Street. And investors who choose to jump in during 2019 will be shooting for their fifth straight year of market-beating returns.
In this article: CVX, IBM, JPM, KO, MRK, PFE, PG, VZ, XOM, CSCO
Read
All Posts

PARTNER HEADLINES

Latest Tweets for $PFE

No tweets yet!

$PFE

Comments Status Updates
Exact Sciences: Poised For Further Growth
James Dean Samuels • 11/22/2018 6:59:36 PM

Great article! Analyst consensus = strong buy with $90 price target. $PFE $EXAS

1 to 1 of 1 comments